Literature DB >> 19955304

Common threads in persistent viral infections.

Melissa Kane1, Tatyana Golovkina.   

Abstract

Most viral infections are self-limiting, resulting in either clearance of the pathogen or death of the host. However, a subset of viruses can establish permanent infection and persist indefinitely within the host. Even though persisting viruses are derived from various viral families with distinct replication strategies, they all utilize common mechanisms for establishment of long-lasting infections. Here, we discuss the commonalities between persistent infections with herpes-, retro-, flavi-, arena-, and polyomaviruses that distinguish them from acutely infecting viral pathogens. These shared strategies include selection of cell subsets ideal for long-term maintenance of the viral genome, modulation of viral gene expression, viral subversion of apoptotic pathways, and avoidance of clearance by the immune system.

Entities:  

Mesh:

Year:  2009        PMID: 19955304      PMCID: PMC2863747          DOI: 10.1128/JVI.01905-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  86 in total

Review 1.  Immune control of HSV-1 latency.

Authors:  Vilma Decman; Michael L Freeman; Paul R Kinchington; Robert L Hendricks
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

2.  SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells.

Authors:  Christopher S Sullivan; Adam T Grundhoff; Satvir Tevethia; James M Pipas; Don Ganem
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

3.  The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells.

Authors:  Jacob Nattermann; Hans Dieter Nischalke; Valeska Hofmeister; Golo Ahlenstiel; Henning Zimmermann; Ludger Leifeld; Elisabeth H Weiss; Tilman Sauerbruch; Ulrich Spengler
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

Review 4.  Global epidemiology of hepatitis C virus infection.

Authors:  Colin W Shepard; Lyn Finelli; Miriam J Alter
Journal:  Lancet Infect Dis       Date:  2005-09       Impact factor: 25.071

5.  An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor.

Authors:  Shuang Tang; Andrea S Bertke; Amita Patel; Kening Wang; Jeffrey I Cohen; Philip R Krause
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-04       Impact factor: 11.205

Review 6.  HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.

Authors:  John M Taylor; Christophe Nicot
Journal:  Apoptosis       Date:  2008-06       Impact factor: 4.677

7.  MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs.

Authors:  Jennifer Lin Umbach; Martha F Kramer; Igor Jurak; Heather W Karnowski; Donald M Coen; Bryan R Cullen
Journal:  Nature       Date:  2008-07-02       Impact factor: 49.962

Review 8.  Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.

Authors:  Johannes G Bode; Erwin D Brenndörfer; Dieter Häussinger
Journal:  Biol Chem       Date:  2008-10       Impact factor: 3.915

Review 9.  Towards an understanding of the molecular basis of herpes simplex virus latency.

Authors:  S Efstathiou; C M Preston
Journal:  Virus Res       Date:  2005-08       Impact factor: 3.303

Review 10.  The HTLV-1 Tax interactome.

Authors:  Mathieu Boxus; Jean-Claude Twizere; Sébastien Legros; Jean-François Dewulf; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2008-08-14       Impact factor: 4.602

View more
  26 in total

1.  Antibodies to human IL-10 neutralize ebvIL-10-mediated cytokine suppression but have no effect on cmvIL-10 activity.

Authors:  Noelle D Brodeur; Juliet V Spencer
Journal:  Virus Res       Date:  2010-08-20       Impact factor: 3.303

Review 2.  Genome editing and the next generation of antiviral therapy.

Authors:  Daniel Stone; Nixon Niyonzima; Keith R Jerome
Journal:  Hum Genet       Date:  2016-06-08       Impact factor: 4.132

3.  Type I Interferon acts as a major barrier to the establishment of infectious bursal disease virus (IBDV) persistent infections.

Authors:  Laura Broto; Nicolás Romero; Fernando Méndez; Elisabet Diaz-Beneitez; Oscar Candelas-Rivera; Daniel Fuentes; Liliana L Cubas-Gaona; Céline Courtillon; Nicolas Eterradossi; Sébastien M Soubies; Juan R Rodríguez; Dolores Rodríguez; José F Rodríguez
Journal:  J Virol       Date:  2020-12-16       Impact factor: 5.103

4.  Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels.

Authors:  Andrew W Lee; Nan Wang; Tara M C Hornell; James J Harding; Chetan Deshpande; Laura Hertel; Vashti Lacaille; Achal Pashine; Claudia Macaubas; Edward S Mocarski; Elizabeth D Mellins
Journal:  Mol Immunol       Date:  2011-03-31       Impact factor: 4.407

Review 5.  CRISPR-Cas based targeting of host and viral genes as an antiviral strategy.

Authors:  Lulia Koujah; Deepak Shukla; Afsar R Naqvi
Journal:  Semin Cell Dev Biol       Date:  2019-04-08       Impact factor: 7.727

6.  Persistent Infection and Transmission of Senecavirus A from Carrier Sows to Contact Piglets.

Authors:  Mayara F Maggioli; Maureen H V Fernandes; Lok R Joshi; Bishwas Sharma; Megan M Tweet; Jessica C G Noll; Fernando V Bauermann; Diego G Diel
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

7.  A single-amino-acid change in murine norovirus NS1/2 is sufficient for colonic tropism and persistence.

Authors:  Timothy J Nice; David W Strong; Broc T McCune; Calvin S Pohl; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

8.  Apoptotic response of chicken embryonic fibroblast cells to infectious bursal disease virus infections reflects viral pathogenicity.

Authors:  Shahla Shahsavandi; Mohammad Majid Ebrahimi; Kaveh Sadeghi; Homayoon Mahravani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-07-04       Impact factor: 2.416

9.  A targeted mutation within the feline leukemia virus (FeLV) envelope protein immunosuppressive domain to improve a canarypox virus-vectored FeLV vaccine.

Authors:  Géraldine Schlecht-Louf; Marianne Mangeney; Hanane El-Garch; Valérie Lacombe; Hervé Poulet; Thierry Heidmann
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

Review 10.  DNA viruses and cancer: insights from evolutionary biology.

Authors:  Nitesh Vinodbhai Pandey
Journal:  Virusdisease       Date:  2020-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.